Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Concentra Group Holdings Parent, Inc.CON · Entity 4001 | Director | August 21, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Concentra Group Holdings Parent, Inc.
Report date August 21, 2026 · Filed September 01, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,663,794 |
Reported balance
After 2026-08-21 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-08-21 · Disposition to issuer · Disposed 770,000 · Balance 4,663,794 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F3: The total number of securities reported has been updated to correct an administrative error. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio Descendants Trust | 882,115 |
Reported balance
After 2026-08-21 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-08-21 · Disposition to issuer · Disposed 150,000 · Balance 882,115 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F4: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio | 196,286 |
Reported balance
After 2026-08-21 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2026-08-21 · Disposition to issuer · Disposed 30,000 · Balance 196,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F5: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio | 196,286 |
Reported balance
After 2026-08-21 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2026-08-21 · Disposition to issuer · Disposed 30,000 · Balance 196,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F6: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio | 206,286 |
Reported balance
After 2026-08-21 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2026-08-21 · Disposition to issuer · Disposed 20,000 · Balance 206,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F7: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectThe Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio | 503,455 |
Reported balance
Holding disclosure · report date 2026-08-21 · row 6
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 6 · Balance 503,455 F8: These shares were inadvertently omitted from the original Form 4 filing. No change in the Reporting Person's beneficial ownership of these shares has occurred. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee.
F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder.
F3: The total number of securities reported has been updated to correct an administrative error.
F4: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F5: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F6: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F7: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F8: These shares were inadvertently omitted from the original Form 4 filing. No change in the Reporting Person's beneficial ownership of these shares has occurred.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SELECT MEDICAL HOLDINGS CORP
Report date June 30, 2026 · Filed July 01, 2026
Section 16 reporting ended · disclosed 2026-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Other · Disposed 7,081,788 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F2: Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio Descendants Trust | 0 |
Last balance in matching sequence
After 2026-06-30 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2026-06-30 · Other · Disposed 1,000,000 · Balance 279,000 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F3: Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Row 3 · 2026-06-30 · Disposition to issuer · Disposed 279,000 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F5: At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio | 0 |
Reported balance
After 2026-06-30 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F6: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio | 0 |
Reported balance
After 2026-06-30 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F7: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio | 0 |
Reported balance
After 2026-06-30 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F8: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).
F2: Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F3: Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F5: At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest.
F6: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F7: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F8: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2023 Filed Mar 8, 2023 22:54 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 621,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004510 · form4-03082023_100311.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · By the Rocco A. Ortenzio 2014 Trust for Robert A. Ortenzio Disclosed balance after: 0 F1 · kind: 621,313 shares were previously owned by, and were contributed by, The Rocco A. Ortenzio 2014 Trust FBO Robert A. Ortenzio to Robert A. Ortenzio. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 22:54 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 621,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004510 · form4-03082023_100311.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,039,668 F1 · kind: 621,313 shares were previously owned by, and were contributed by, The Rocco A. Ortenzio 2014 Trust FBO Robert A. Ortenzio to Robert A. Ortenzio. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 21:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 346,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009908 · form4-09232022_050901.xml · nonDerivative · entry 6 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · By the Rocco A. Ortenzio 2014 Trust for Robert A. Ortenzio Disclosed balance after: 621,313 F6 · kind: 346,368 shares were previously owned by, and were contributed by, The Rocco A. Ortenzio July 2020 GRAT to The Rocco A. Ortenzio 2014 Trust FBO Robert A. Ortenzio. F5 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 21:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 138,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009908 · form4-09232022_050901.xml · nonDerivative · entry 5 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio Disclosed balance after: 280,415 F2 · kind: 138,547 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to The Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio. F5 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 21:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 138,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009908 · form4-09232022_050901.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio Disclosed balance after: 280,415 F3 · kind: 138,547 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to The Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio. F5 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 21:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 138,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009908 · form4-09232022_050901.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio Disclosed balance after: 280,415 F4 · kind: 138,548 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to The Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio. F5 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 21:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 652,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009908 · form4-09232022_050901.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio July 2020 GRAT Disclosed balance after: 0 F1 · kind: 236,450 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to Robert A. Ortenzio. F2 · kind: 138,547 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to The Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio. F3 · kind: 138,547 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to The Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio. F4 · kind: 138,548 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to The Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio. F5 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 21:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 236,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009908 · form4-09232022_050901.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,418,355 F1 · kind: 236,450 shares were previously owned by, and were contributed by, The Robert A. Ortenzio July 2020 GRAT to Robert A. Ortenzio. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 21:56 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 481,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008728 · form4-08162022_020802.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,181,905 F1 · kind: 481,731 shares were previously owned by, and were contributed by, The Rocco A. Ortenzio Separate Non-Exempt Descendants Trust to Robert Ortenzio. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 00:29 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008216 · form4-08032022_050802.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700,174 F1 · kind: Grant of shares of restricted stock to Executive Officers of the Issuer, which will vest annually on the anniversary of the grant date until fully vested on August 1, 2025. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 235,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010052 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450,174 F1 · kind: 235,211 shares were previously owned by, and were contributed by, The Robert A. Ortenzio October 2019 GRAT to Robert Ortenzio. Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 21:29 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 147,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008480 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,214,963 F1 · kind: 147,908 shares were previously owned by, and were contributed by, The Robert A Ortenzio July 2020 GRAT to Robert Ortenzio. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:17 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007950 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,067,055 F1 · kind: Grant of shares of restricted stock to Executive Officers of the Issuer, which will vest in full on August 3, 2024, the third anniversary of the grant date. Read SEC document |
| July 31, 2021 Filed Aug 3, 2021 20:57 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | Tax withholdingCommon Stock | 109,825 | $39.45 | $4,332,596.25 |
DisclosureSEC source: 0001179110-21-007866 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,867,055 F1 · kind: Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 13:56 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 9,985 | $34.02 | $339,689.70 |
DisclosureSEC source: 0001179110-21-003298 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,529,000 F3 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.19, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 13:56 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 14,978 | $34.02 | $509,551.56 |
DisclosureSEC source: 0001179110-21-003298 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,976,880 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.19, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 22:27 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 48,422 | $34.00 | $1,646,348.00 |
DisclosureSEC source: 0001179110-21-003221 · edgar.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,538,985 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F3 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 22:27 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 72,631 | $34.00 | $2,469,454.00 |
DisclosureSEC source: 0001179110-21-003221 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,991,858 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:27 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,995 | $34.00 | $1,733,830.00 |
DisclosureSEC source: 0001179110-21-003221 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,587,407 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F3 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:27 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 76,493 | $34.00 | $2,600,762.00 |
DisclosureSEC source: 0001179110-21-003221 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,064,489 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 23:13 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 10,598 | $34.00 | $360,332.00 |
DisclosureSEC source: 0001179110-21-002909 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,638,402 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F3 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 23:13 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 15,898 | $34.00 | $540,532.00 |
DisclosureSEC source: 0001179110-21-002909 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,140,982 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 22:34 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,625 | $32.52 | $1,646,325.00 |
DisclosureSEC source: 0001179110-21-002446 · edgar.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,649,000 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.69, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 22:34 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 75,938 | $32.52 | $2,469,503.76 |
DisclosureSEC source: 0001179110-21-002446 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,156,880 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.69, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:34 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 69,375 | $32.50 | $2,254,687.50 |
DisclosureSEC source: 0001179110-21-002446 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,699,625 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F3 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:34 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 104,062 | $32.50 | $3,382,015.00 |
DisclosureSEC source: 0001179110-21-002446 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,232,818 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:37 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 3,804,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001435 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Rocco A. Ortenzio Descendants Trust Disclosed balance after: 0 F1 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:37 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 1,445,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001435 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Rocco A. Ortenzio Descendants Trust Disclosed balance after: 3,804,805 F1 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 22:42 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 108,627 | $31.02 | $3,369,609.54 |
DisclosureSEC source: 0001179110-21-000477 · edgar.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,769,000 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.21, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 22:42 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 162,941 | $31.02 | $5,054,429.82 |
DisclosureSEC source: 0001179110-21-000477 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,336,880 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.21, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 22:42 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 4,004 | $31.00 | $124,124.00 |
DisclosureSEC source: 0001179110-21-000477 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,877,627 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F3 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 22:42 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 6,006 | $31.00 | $186,186.00 |
DisclosureSEC source: 0001179110-21-000477 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,499,821 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 00:50 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 87,369 | $29.86 | $2,608,838.34 |
DisclosureSEC source: 0001179110-21-000377 · edgar.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,881,631 F3 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.75 to $31.00, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 00:50 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 131,053 | $29.86 | $3,913,242.58 |
DisclosureSEC source: 0001179110-21-000377 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,505,827 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.75 to $31.00, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 00:50 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 56,000 | $28.05 | $1,570,800.00 |
DisclosureSEC source: 0001179110-21-000377 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,969,000 F3 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.32, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 00:50 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 84,000 | $28.05 | $2,356,200.00 |
DisclosureSEC source: 0001179110-21-000377 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,636,880 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.32, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 28, 2020 Filed Oct 29, 2020 21:39 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-010714 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418,036 F1 · kind: 125,000 shares were previously owned by, and were contributed by, Robert A. Ortenzio to the Robert A. Ortenzio Descendants Trust. Read SEC document |
| August 25, 2020 Filed Dec 22, 2020 21:42 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-012181 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Rocco A. Ortenzio Descendants Trust Disclosed balance after: 5,250,000 F1 · kind: Gift of 2,000,000 shares from Rocco A. Ortenzio to the Rocco A. Ortenzio Descendants Trust. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 23:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008584 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,243,036 F1 · kind: Grant of shares of restricted stock to Executive Officers of the Issuer, which will vest in full on July 28, 2023, the third anniversary of the grant date. Read SEC document |
| March 19, 2020 Filed Mar 20, 2020 21:14 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004031 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,093,036 Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 22:19 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 11,459 | $28.17 | $322,800.03 |
DisclosureSEC source: 0001179110-20-002401 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,393,036 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.10 to $28.21, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 08, 2020 Filed Jan 14, 2020 11:05 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000538 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404,495 Read SEC document |
| November 26, 2019 Filed Dec 3, 2019 00:03 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GiftCommon Stock | 56,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-012194 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Indirect · By the Rocco A. Ortenzio 2014 Trust for Robert A. Ortenzio Disclosed balance after: 56,669 F1 · balance_after: The shares were previously owned by, and contributed by, the Rocco A. Ortenzio July 2017 GRAT to the Rocco A. Ortenzio 2014 Revocable Trust for Robert A. Ortenzio. F6 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 15, 2019 Filed Nov 15, 2019 21:59 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 189,638 | $20.01 | $3,794,656.38 |
DisclosureSEC source: 0001179110-19-011759 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,263,264 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.07, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:59 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 13,507 | $20.00 | $270,140.00 |
DisclosureSEC source: 0001179110-19-011759 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,452,902 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 22:31 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 66,679 | $20.00 | $1,333,580.00 |
DisclosureSEC source: 0001179110-19-011662 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,466,409 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.04, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 18,356 | $20.00 | $367,120.00 |
DisclosureSEC source: 0001179110-19-011662 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,533,088 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.03, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 22:23 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 3,136 | $20.00 | $62,720.00 |
DisclosureSEC source: 0001179110-19-011580 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,551,444 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 22:23 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 7,171 | $20.01 | $143,491.71 |
DisclosureSEC source: 0001179110-19-011580 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,554,580 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 22:23 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 78,072 | $20.00 | $1,561,440.00 |
DisclosureSEC source: 0001179110-19-011580 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,561,751 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.03, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.